Metabolic Acidosis: Comprehensive Overview
Introduction and Definition
Metabolic acidosis is a primary reduction in serum bicarbonate (<22 mmol/L) associated with blood pH <7.35, where the body attempts compensation by increasing ventilation to eliminate CO2. 1
- Metabolic acidosis develops when the kidney's mechanisms for maintaining acid-base homeostasis are overwhelmed or impaired, occurring in situations such as rapid production of nonvolatile acids, abnormally high bicarbonate losses, and impaired acid excretion by the kidney 2
- Low serum bicarbonate concentrations almost always indicate metabolic acidosis 1
- The normal serum bicarbonate range is 22-26 mmol/L, though more recent evidence suggests 23-30 mEq/L to avoid missing acid-base disorders 1
Pathophysiology
The kidney maintains acid-base homeostasis through elimination of protons and reabsorption/generation of bicarbonate; metabolic acidosis occurs when these mechanisms fail. 2
Primary Mechanisms
- In Chronic Kidney Disease, the kidneys' impaired ability to excrete hydrogen ions and synthesize ammonia leads to acid accumulation in the body 1
- Western dietary patterns with high animal protein, cereal, and grain consumption combined with low fruit and vegetable intake create an imbalance between nonvolatile acids and available alkali 1
- Animal proteins contain sulfur-containing amino acids that produce nonvolatile acids during metabolism 1
- A fall in extracellular and intracellular pH affects cellular function via different mechanisms, requiring treatment directed at improving both parameters 3
Compensatory Response
- The body attempts to compensate for metabolic acidosis by increasing ventilation to eliminate CO2 1
- Patients with severe acidosis may self-ventilate their PCO2 to very low levels as compensation for the metabolic acidosis 4
- When initiating mechanical ventilation in these patients, great care must be taken to avoid a rapid rise of PCO2, even to normal levels, before acidosis has been partly corrected 4
Systemic Effects of Acidosis
Acute metabolic acidosis is associated with increased morbidity and mortality through multiple organ system effects. 3
Cardiovascular Effects
- Depressive effects on cardiovascular function and facilitation of cardiac arrhythmias 3
- Hypotension (systolic blood pressure <80 mm Hg or <70 mm Hg if <1 year) complicates about 25% of cases presenting with severe acidosis (base deficit >15 mmol/l) 4
- Acidosis directly stimulates endothelial cell secretion of endothelin 1, which enhances sodium-hydrogen exchanger 3 activity, increasing luminal hydrogen ion secretion 1
Metabolic and Nutritional Effects
- Protein catabolism is increased, leading to muscle wasting and malnutrition 1
- Correction of acidemia has been associated with increased serum albumin and decreased protein degradation rates 1
- Acidosis increases oxidation of branched chain amino acids 5
- Correction of metabolic acidosis increases essential amino acid concentrations, promoting cellular influx and decreasing efflux of branched chain amino acids 1
Bone and Mineral Effects
- Bone demineralization occurs, contributing to renal osteodystrophy 1
- Chronic metabolic acidosis alters the homeostatic relationships between blood ionized calcium, PTH, and 1,25(OH)₂D₃, leading to bone dissolution 1
- Maintaining serum bicarbonate ≥22 mmol/L is associated with normal bone biopsy results, versus mixed osteodystrophy at levels <20 mmol/L 1
Growth and Development
- Growth retardation in children with CKD may occur due to chronic metabolic acidosis 1
- In children with renal tubular acidosis, normalization of serum bicarbonate is important for normal growth parameters 5
Immune and Inflammatory Effects
- Stimulation of inflammation and suppression of the immune response 3
Electrolyte Disturbances
- Acidosis causes hyperkalemia due to transcellular shift of potassium 5
- Hyperkalaemia may complicate cases with severe metabolic acidosis at admission 4
Etiology
Determining the presence or absence of an anion gap is the first step in ascertaining the etiology of metabolic acidosis. 2
High Anion Gap Metabolic Acidosis
Lactic Acidosis
- Lactic acidosis evolves from various conditions, either with or without systemic hypoxia 6
- Lactic acidosis due to tissue hypoxia requires primary focus on improving oxygen delivery 7
Ketoacidosis
- Diabetic ketoacidosis: bicarbonate of 15-18 mmol/L indicates mild DKA, while levels below 15 mmol/L indicate moderate to severe DKA 1
- The primary goal in DKA is restoring circulatory volume and tissue perfusion, along with resolution of ketoacidosis and correction of electrolyte imbalances 5
Renal Failure
- Acute kidney injury with severe acidosis (pH <7.20) represents refractory acidosis requiring urgent intervention 5
- In CKD stages 3-5, serum bicarbonate levels should be measured to monitor for metabolic acidosis 1
Toxic Ingestions
- The presence or absence of an osmolal gap, urine pH, and serum potassium levels may be useful in certain settings 2
Normal Anion Gap (Hyperchloremic) Metabolic Acidosis
Gastrointestinal Losses
- Abnormally high bicarbonate losses through gastrointestinal tract 2
Renal Tubular Acidosis
- Impaired acid excretion by the kidney 2
Iatrogenic Causes
- Unbalanced electrolyte preparations can induce hyperchloremic metabolic acidosis 6
- Hyperchloremic acidosis potentially worsens kidney-related outcome parameters 6
Recovery Phase
- Recovery from diabetic ketoacidosis can cause acidosis with a normal anion gap 1
Approach to Assessment
Appropriate evaluation of acute metabolic acidosis includes assessment of acid-base parameters, including pH, partial pressure of CO2 and HCO3- concentration in arterial blood in stable patients, and also in central venous blood in patients with impaired tissue perfusion. 3
Initial Laboratory Assessment
Arterial Blood Gas Analysis
Serum Bicarbonate and Anion Gap
Additional Laboratory Tests
Clinical Assessment
- Assess conscious level using AVPU scale (Alert, responds to Voice, responds to Pain, or Unresponsive) or Glasgow coma scale 4
- Evaluate hemodynamic status: blood pressure, heart rate, capillary refill time (≥2 seconds is a reasonable prognostic indicator) 4
- Assess volume status: signs of volume depletion such as orthostatic hypotension, decreased skin turgor, and elevated BUN/creatinine ratio 1
- Urine output of <1 ml/kg/hour, in the absence of urinary retention or established renal failure, indicates impaired renal perfusion secondary to hypovolemia 4
Systematic Approach Algorithm
Step 1: Confirm metabolic acidosis
- pH <7.35 and HCO3- <22 mmol/L 1
Step 2: Calculate anion gap
- High anion gap (>12): Consider lactic acidosis, ketoacidosis, renal failure, toxic ingestions 2
- Normal anion gap: Consider GI losses, RTA, iatrogenic causes, recovery phase of DKA 1, 2
Step 3: Assess severity
- Bicarbonate ≥22 mmol/L: Monitor without pharmacological intervention 1
- Bicarbonate 18-22 mmol/L: Consider oral alkali supplementation 1
- Bicarbonate <18 mmol/L: Initiate pharmacological treatment 1
- pH <7.20: Consider urgent intervention including possible dialysis 5
- pH <6.9-7.0: Consider bicarbonate therapy in specific contexts 1, 5
Step 4: Identify underlying cause
- History, physical examination, and targeted laboratory tests 2
Step 5: Initiate cause-specific treatment
- Address underlying etiology as primary intervention 5
Triple Disorder
A triple disorder exists when three primary acid-base disturbances occur simultaneously, requiring careful analysis of expected compensation versus observed values.
Recognition Approach
- Calculate expected compensation for the primary disorder 3
- If the observed values differ significantly from expected compensation, consider additional primary disorders 3
- Measure arterial blood gases to determine pH and PaCO2 for complete acid-base assessment 1
Common Triple Disorder Scenarios
Metabolic acidosis + metabolic alkalosis + respiratory disorder
- Example: Patient with DKA (metabolic acidosis) + vomiting (metabolic alkalosis) + pneumonia (respiratory acidosis) 2
Detection Strategy
Clinical Pitfall
- Failing to recognize triple disorders can lead to inappropriate treatment, as the pH may appear near-normal despite severe underlying derangements 3
Role of ABG in Toxicology
The presence or absence of an osmolal gap, combined with anion gap analysis and ABG findings, is crucial for identifying toxic ingestions causing metabolic acidosis. 2
Key Toxicological Applications
Osmolal Gap Calculation
Anion Gap Analysis
Serial ABG Monitoring
Clinical Algorithm for Toxic Ingestions
Step 1: Obtain ABG, basic metabolic panel, serum osmolality 2
Step 2: Calculate anion gap and osmolal gap 2
Step 3: If high AG + high osmolal gap → suspect toxic alcohol 2
Step 4: Initiate specific antidote therapy and consider hemodialysis 3
Step 5: Serial ABG monitoring every 2-4 hours until stabilized 3
Role of ABG in Resuscitation of Undifferentiated Shock
In patients with undifferentiated shock and impaired tissue perfusion, central venous blood gas analysis provides crucial information about tissue perfusion and metabolic status. 3
Initial Assessment
- Arterial blood gas in stable patients; central venous blood gas in patients with impaired tissue perfusion 3
- Assess for metabolic acidosis as marker of inadequate tissue perfusion 3
- Base deficit >15 mmol/l indicates severe acidosis and increased risk of complications 4
Resuscitation Guidance
Volume Resuscitation
- In the absence of coma (Glasgow coma score <8), volume resuscitation with 20-40 ml/kg of either 0.9% saline or 4.5% human albumin solution safely corrects hemodynamic features of shock 4
- Volume resuscitation should proceed cautiously and be stopped once signs of circulatory failure have been reversed 4
- For any patient with persisting features of shock despite 40 ml/kg of fluid, elective intubation and ventilation, and placement of a central venous catheter to guide further fluid management is recommended 4
Serial ABG Monitoring
Treatment Priorities
Special Considerations in Shock
- Metabolic acidosis resolves with correction of hypovolemia and treatment of underlying cause 4
- Sodium bicarbonate should not be used to treat metabolic acidosis arising from tissue hypoperfusion in sepsis; instead focus treatment on restoring tissue perfusion with fluid resuscitation and vasopressors 5
- The effectiveness of sodium bicarbonate to correct metabolic acidosis from septic shock is unsure, and acidosis may have protective effects 5
Role of Sodium Bicarbonate
Treatment of metabolic acidosis must be directed at the underlying cause rather than routine bicarbonate administration, as sodium bicarbonate has not demonstrated mortality benefit in most acute organic acidoses and may worsen intracellular acidosis. 5
Evidence-Based Indications for Bicarbonate Therapy
Chronic Kidney Disease
- Initiate sodium bicarbonate when serum bicarbonate falls below 22 mmol/L, with aggressive treatment required when levels drop below 18 mmol/L 1
- Oral sodium bicarbonate (2-4 g/day or 25-50 mEq/day) divided into 2-3 doses 1
- Target maintenance is serum bicarbonate ≥22 mmol/L at all times 1
- Monthly monitoring of serum bicarbonate initially, then at least every 4 months once stable 1
Severe Acute Metabolic Acidosis
- Consider bicarbonate therapy only when pH falls below 6.9-7.0 1, 5
- In diabetic ketoacidosis, bicarbonate therapy is generally NOT indicated unless pH falls below 6.9-7.0 5
- For cardiac arrest, rapid administration of 44.6-100 mEq of bicarbonate initially may be given, with subsequent doses of 44.6-50 mEq every 5-10 minutes as needed 1
Specific Clinical Scenarios
- In malignant hyperthermia, sodium bicarbonate administration is considered at a low threshold, as low pH values are associated with poor outcomes 1
- Sodium bicarbonate aids potassium reuptake into cells and alkalinizes urine in malignant hyperthermia 1
Contraindications and Cautions
Bicarbonate therapy should be avoided or used cautiously in several situations:
- Advanced heart failure with volume overload 1
- Severe hypertension poorly controlled 1
- Significant edema 1
- Diabetic ketoacidosis (unless pH <6.9) 5
- Lactic acidosis from tissue hypoperfusion 5
- Septic shock 5
Mechanisms of Potential Harm
- Administration of bicarbonate solutions may worsen intracellular acidosis 5, 3
- Reduction in ionized calcium 5, 3
- Production of hyperosmolality 5, 3
- Increased carbon dioxide production with subsequent intracellular acidosis 6
Monitoring During Bicarbonate Therapy
Critical monitoring parameters include:
- Serum bicarbonate levels 1
- Blood pressure 1
- Serum potassium 1
- Fluid status 1
- Arterial blood gases to assess pH and bicarbonate response 1
- Ensure treatment doesn't cause hypertension or hyperkalemia 1
Treatment Goals
- The treatment goal is to increase bicarbonate levels toward but not exceeding the normal range 1
- In severe acute metabolic acidosis requiring bicarbonate, the goal is to achieve a pH of 7.2-7.3, not normalization 1
- The goal of achieving a total CO₂ of approximately 20 mEq/L initially is appropriate 1
Alternative Therapies
- Administration of tris(hydroxymethyl)aminomethane (THAM) improves acidosis without producing intracellular acidosis and its value as a form of base is worth further investigation 3
- Selective sodium-hydrogen exchanger 1 (NHE1) inhibitors have been shown to improve hemodynamics and reduce mortality in animal studies of acute lactic acidosis 3
- Dichloroacetate reduces lactic acidosis in African children, but effect on mortality unknown 4
Etiology-Specific Bicarbonate Use
Diabetic Ketoacidosis
- Focus on insulin therapy, fluid resuscitation, and electrolyte replacement as primary treatment 5
- Continuous intravenous insulin is the standard of care for critically ill and mentally obtunded patients 5
- Bicarbonate administration has not been shown to improve resolution of acidosis or time to discharge 5
- For children with pH <6.9,1-2 mEq/kg IV of sodium bicarbonate can be given slowly 5
Severe Malaria
- Metabolic acidosis resolves with correction of hypovolemia and treatment of anemia by adequate blood transfusion 4
- No evidence supports sodium bicarbonate use 4
Chronic Kidney Disease with Decompensation
- Correction of metabolic acidosis reduces protein catabolism and prevents muscle wasting 1
- Correction improves albumin synthesis, increasing serum albumin levels 1
- Correction prevents bone demineralization, improving bone histology 1
- May reduce hospitalizations in patients with corrected acidosis 1
Dosing Considerations
- Initial dose: 2-4 g/day (25-50 mEq/day) divided into 2-3 doses for standard oral dosing 1
- For dialysis patients, higher dialysate bicarbonate concentrations (38 mmol/L) combined with oral supplementation 1
- Higher dialysate lactate or bicarbonate levels plus oral sodium bicarbonate for peritoneal dialysis patients 1
Common Pitfalls
- Do not use bicarbonate as first-line treatment for lactic acidosis or ketoacidosis 5
- Do not delay definitive treatment (dialysis, insulin, fluid resuscitation) while attempting bicarbonate therapy 5
- Avoid citrate-containing alkali salts in CKD patients exposed to aluminum salts, as they may increase aluminum absorption 5
Approach to Respiratory Disorders
Respiratory acidosis is characterized by elevated PaCO2 (>46 mmHg), and in chronic respiratory acidosis, the kidneys retain bicarbonate to buffer the acidity, resulting in high bicarbonate levels as a compensatory mechanism, not the primary disorder. 1
Distinguishing Respiratory from Metabolic Disorders
Acute Respiratory Acidosis
Chronic Respiratory Acidosis
Compensated Chronic Respiratory Acidosis
Diagnostic Algorithm for Respiratory Disorders
Step 1: Obtain ABG
- Assess pH, PCO2, and bicarbonate 1
Step 2: Determine primary disorder
Step 3: Assess compensation
- Calculate expected metabolic compensation 3
- If bicarbonate is higher than expected: Chronic respiratory acidosis with renal compensation 1
- If bicarbonate is lower than expected: Coexisting metabolic acidosis 3
Step 4: Identify underlying cause
- COPD exacerbation (about 20% of acute exacerbations have respiratory acidosis) 7
- Chest wall deformities or muscle weakness 1
- Severe brain injury affecting respiratory drive 1
- Obesity hypoventilation syndrome 1
Management of Acute Respiratory Acidosis
Immediate Interventions
Ventilation Considerations
- When initiating ventilation in patients with severe metabolic acidosis who have compensated with low PCO2, great care should be taken to avoid a rapid rise of PCO2, even to normal levels, before acidosis has been partly corrected 4
- Children who remain unconscious (Glasgow coma score ≤8) or have features suggestive of raised intracranial pressure warrant elective intubation and ventilation 4
Specific Treatment Based on Etiology
- For COPD exacerbations: Optimize bronchodilators, corticosteroids, and antibiotics if indicated 1
- Consider non-invasive ventilation (NIV) if pH falls below 7.35 despite medical management 1
- For obesity hypoventilation syndrome: Consider weight loss, positive airway pressure therapy (CPAP/BiPAP), and treatment of concurrent obstructive sleep apnea 1
Management of Chronic Respiratory Acidosis
The primary goal is managing the underlying respiratory disorder, not correcting the compensatory bicarbonate elevation. 1
Oxygen Management
- Target oxygen saturation of 88-92% in patients with chronic hypercapnia, rather than attempting to correct the bicarbonate level 1
- Prior to blood gas availability, use 24% Venturi mask at 2-3 L/min or nasal cannulae at 1-2 L/min, or 28% Venturi mask at 4 L/min 1
- Avoid excessive oxygen therapy, as PaO2 above 10.0 kPa (75 mmHg) increases the risk of worsening respiratory acidosis in patients with hypercapnic respiratory failure 1
Monitoring
- Serial blood gases are essential to detect transition from compensated to decompensated respiratory acidosis 1
- Repeat blood gases at 30-60 minutes after any change in oxygen therapy or if clinical deterioration occurs 1
- In patients with baseline compensated respiratory acidosis, measure blood gases on arrival for any acute illness 1
When NOT to Treat Bicarbonate
Special Clinical Scenarios
- Initiate NIV early if pH falls below 7.35 in patients with baseline compensated respiratory acidosis 1
- Maintain target oxygen saturation 88-92% in the postoperative period for patients with chronic hypercapnia 1
- Consider prophylactic NIV in the immediate postoperative period for patients with severe baseline hypercapnia (PCO2 >55 mmHg) 1
Management of Mixed Disorders
When metabolic acidosis coexists with respiratory disorders, treatment priorities must be carefully considered.
Metabolic Acidosis + Chronic Respiratory Acidosis
Diuretic-Induced Metabolic Alkalosis in COPD
- Use acetazolamide to reduce bicarbonate buffering capacity in patients with chronic hypercapnia and metabolic alkalosis, allowing for continued necessary diuresis for heart failure without worsening alkalosis 1
- Acetazolamide promotes urinary bicarbonate loss, directly lowering elevated HCO3 levels 1
- Monitor potassium levels closely when starting acetazolamide, as it can cause hypokalemia 1
Common Pitfalls in Respiratory Disorders
- Do not attempt to "correct" elevated bicarbonate in chronic respiratory acidosis with normal pH 1
- Avoid excessive oxygen supplementation in patients with chronic hypercapnia 1
- Do not rapidly normalize PCO2 during mechanical ventilation in patients who have compensated with severe metabolic acidosis 4
- Recognize that rising CO2 on basic metabolic panel during diuresis reflects bicarbonate, not arterial PCO2 1
Hospitalization Criteria
Patients with severe metabolic acidosis (bicarbonate <18 mmol/L) require hospitalization for pharmacological treatment and close monitoring. 1
Additional indications for hospitalization:
- Acute illness or catabolic state (critical illness, major surgery, acute kidney injury superimposed on CKD) 1
- Symptomatic complications (protein wasting, severe muscle weakness, altered mental status, inability to maintain oral intake) 1
- Severe electrolyte disturbances (hyperkalemia, severe hypocalcemia, other life-threatening metabolic derangements) 1
- Need for kidney replacement therapy initiation 1
Outpatient management is appropriate for: